Acura Pharmaceuticals, Inc. (ACUR)

OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0015 (-75.00%)
At close: Feb 12, 2026
-91.23%
Market Cap 33.33K
Revenue (ttm) 1.56M
Net Income (ttm) -879.00K
Shares Out 66.65M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 220
Average Volume 3,763
Open 0.0005
Previous Close 0.0020
Day's Range 0.0005 - 0.0005
52-Week Range 0.0001 - 0.1755
Beta 67.98
RSI 47.87
Earnings Date n/a

About Acura Pharmaceuticals

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, ... [Read more]

Sector Healthcare
Founded 1935
Employees 9
Stock Exchange OTCMKTS
Ticker Symbol ACUR
Full Company Profile

Financial Performance

In 2021, Acura Pharmaceuticals's revenue was $1.56 million, a decrease of -56.22% compared to the previous year's $3.57 million. Losses were -$879,000, -27.24% less than in 2020.

Financial Statements

News

There is no news available yet.